نتایج جستجو برای: 6b1 igg4 monoclonal antibody

تعداد نتایج: 194103  

Journal: :iranian journal of allergy, asthma and immunology 0
mahdi fasihi-ramandi applied biotechnology research center, baqiyatallah university of medical sciences, tehran, iran. jafar amani applied microbiology research center, baqiyatallah university of medical sciences, tehran, iran. alihatef salmanian department of agricultural biotechnology, national institute of genetic engineering and biotechnology (nigeb), tehran, iran. seyedmohammad moazzeni immunology department, tarbiat modares university, tehran, iran. kazem ahmadi molecular biology research center, baqiyatallah university of medical sciences, tehran, iran.

the b-cell cd20 antigen is one of the most reliable surface targets in immunotherapy of b lymphoma. in this project, we studied the production and characterization of a new monoclonal antibody against chimeric human cd20 extra loops (hcd20 exl). the results showed that clone c12h, igg2/k isotype reacted with the antigen in elisa and immunoblot. the kd value was  found to be 2×10-9m and flow cyt...

Journal: :Current opinion in rheumatology 2011
Ajay Nirula Scott M Glaser Susan L Kalled Frederick R Taylor

PURPOSE OF REVIEW Recent descriptions of the group of clinical disorders collectively defined as IgG4-related systemic disease (IgG4-RSD) have prompted this review of the unique biology of the IgG4 antibody. This article will discuss IgG4 structure and function, the unique phenomenon of half-antibody exchange, and the implications of IgG4 biology for its proposed role in immunologic diseases. ...

2015
Heather Hirsch Elaine Pinheiro Mark Ayers Jared Lunceford Michael Nebozhyn Erin Murphy Mingmei Cai Yanhong Ma Manjiri Sathe Terri McClanahan

Background Pembrolizumab (MK-3475), a humanized monoclonal IgG4 antibody against programmed death receptor 1 (PD-1), is currently being studied in clinical trials across more than 30 types of cancers. Immunotherapy with anti–PD-1 monoclonal antibodies such as pembrolizumab shows robust, durable anti-tumor activity in multiple indications including patients with advanced melanoma. A more complet...

Journal: :The Journal of Experimental Medicine 1996
H Kimata A Yoshida C Ishioka M Fujimoto I Lindley K Furusho

We studied the effects of various chemokines including neutrophil-activating peptide 2 (NAP-2), beta-thromboglobulin (beta-TG), platelet factor 4 (PF-4), melanoma growth stimulating activity (GRO), gamma interferon-induced protein (IP-10), regulated on activation, normal T expressed and secreted (RANTES), macrophage inflammatory protein 1 alpha (MIP-1 alpha), MIP-1 beta, and monocyte chemotacti...

Ali Ahmad Bayat Farzaneh Notash Haghighat Jafar Mahmoudian Mahmood Jeddi-Tehrani, Mahmood Shams Mohammad Reza Rezvani,

Background: Human CD34 is a transmembrane glycoprotein which is expressed in human hematopoietic stem cells (HSCs) and the small- vessel endothelial cells of a variety of tissues. CD34 plays a critical role as a marker for diagnosis and classification of leukemia. Anti CD34 antibodies are used for isolation and purification of HSCs from bone marrow, peripheral blood and cord blood. Objective: ...

Journal: :iranian journal of immunology 0
seyed mahmoud sadjjadi department of parasitology and mycology sadreddin mohseni ardehali department of parasitology and mycology reza adibmanesh department of parasitology and mycology ezzatollah basiri bacteriology and virology, school of medicine, shiraz university of medical sciences, shiraz, iran

background: different methods have been used for characterization of leishmania promastigotes. monoclonal antibodies are useful in characterization of   leishmania spp . both amastogotes and promastigotes. objective: comparing the characterization of   leishmania spp. promastigotes with immunoperoxidase test (avidin-biotin) techniques and an indirect immunofluorescent assay (ifa).   methods: ap...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2015
E Marriott C Praet R Aguiar-Ibáñez J Pellissier R Xu J Wang

REFERENCES Pembrolizumab (MK-3475) is a humanised, anti-programmed cell death 1 (PD-1) monoclonal IgG4 antibody. It is involved in the blockade of immune suppression and reactivation of anergic T-cells in cancer patients. It is believed that due to the high specificity and affinity for PD-1, against which it displays pure antagonist properties, pembrolizumab has the potential to improve the eff...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1993
J Punnonen G Aversa B G Cocks A N McKenzie S Menon G Zurawski R de Waal Malefyt J E de Vries

Recently the cDNA encoding interleukin 13 (IL-13), a T-cell-derived cytokine, was cloned and expressed. The present study demonstrates that IL-13 induces IgG4 and IgE synthesis by human B cells. IL-13-induced IgG4 and IgE synthesis by unfractionated peripheral blood mononuclear cells and highly purified B cells cultured in the presence of activated CD4+ T cells or their membranes. IL-13-induced...

Journal: :Annals of the Rheumatic Diseases 2021

Background: Clinical improvement after B-cell depletion with rituxmab suggests a prominent pathogenic role of B-lymphcytes in IgG4-related disease (IgG4-RD). IgG4-RD, however, relapses most cases together re-expansion clonally divergent plasmablasts indicating that treatment rituximab does not completely abrogates T follicular helper (Tfh)-cells dependent germinal center reactions leading to de...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید